The current study shows that expression of Trx1 in the cytoplasm is associated with poor prognosis in ccRCC but on the other hand higher levels of Trx1 were associated with less advanced clinicopathological features. The gene discussed is TXN; the disease is nonpapillary renal cell carcinoma.